Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection
- PMID: 12794719
- DOI: 10.1002/jmv.10432
Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection
Abstract
Although occult hepatitis B virus (HBV) infection (HBV-DNA in serum in the absence of hepatitis B surface antigen [HBsAg]) is common in chronic hepatitis C, its characteristics are not well known. In this work, the presence of HBV-DNA (by polymerase chain reaction; PCR) and its distribution (by in situ hybridization) in liver biopsies and peripheral blood mononuclear cells (PBMCs) from 32 patients with chronic hepatitis C and occult HBV infection and in 20 HBsAg chronic carriers were determined. The results showed that serum HBV-DNA levels were statistically lower (P = 0.001) in patients with occult HBV infection than in HBsAg chronic carriers. The HBV infection pattern in liver cells was identical between patients with occult HBV infection and those with chronic hepatitis B. However, the mean percentage of HBV-infected hepatocytes was significantly lower (P = 0.001) in patients with occult HBV infection (5 +/- 4.44%) than in HBsAg chronic carriers (17.99 +/- 11.58%). All patients with chronic hepatitis B have HBV-DNA in their PBMCs while this occurred in 50% of the cases with occult HBV infection. In conclusion, patients with occult HBV infection have a low number of HBV-infected hepatocytes and this fact could explain the lack of HBsAg detection and low viremia levels found in these cases.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.J Med Virol. 2004 Jun;73(2):177-86. doi: 10.1002/jmv.20073. J Med Virol. 2004. PMID: 15122790
-
Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.J Med Virol. 2007 Mar;79(3):236-41. doi: 10.1002/jmv.20784. J Med Virol. 2007. PMID: 17245725
-
Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.J Med Virol. 2004 Feb;72(2):203-14. doi: 10.1002/jmv.10547. J Med Virol. 2004. PMID: 14695661
-
Occult hepatitis B virus and hepatitis C virus infections.Rev Med Virol. 2008 May-Jun;18(3):139-57. doi: 10.1002/rmv.569. Rev Med Virol. 2008. PMID: 18265423 Review.
-
Occult hepatitis B virus infection.Transfus Clin Biol. 2004 Feb;11(1):18-25. doi: 10.1016/j.tracli.2003.11.007. Transfus Clin Biol. 2004. PMID: 14980545 Review.
Cited by
-
Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.J Korean Med Sci. 2005 Jun;20(3):433-7. doi: 10.3346/jkms.2005.20.3.433. J Korean Med Sci. 2005. PMID: 15953865 Free PMC article.
-
Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.J Virol. 2005 Dec;79(24):15578-81. doi: 10.1128/JVI.79.24.15578-15581.2005. J Virol. 2005. PMID: 16306629 Free PMC article.
-
Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.Expert Opin Drug Saf. 2017 Jun;16(6):651-672. doi: 10.1080/14740338.2017.1325869. Epub 2017 May 19. Expert Opin Drug Saf. 2017. PMID: 28471314 Free PMC article. Review.
-
Targeted DNA mutagenesis for the cure of chronic viral infections.J Virol. 2012 Sep;86(17):8920-36. doi: 10.1128/JVI.00052-12. Epub 2012 Jun 20. J Virol. 2012. PMID: 22718830 Free PMC article. Review.
-
Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection.Sci Rep. 2021 Jan 8;11(1):200. doi: 10.1038/s41598-020-80594-6. Sci Rep. 2021. PMID: 33420293 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical